
    
      Primary Objectives:

      • To assess the safety and tolerability of single ascending oral doses of ABP-671 in Healthy
      Volunteers (HVs).

      Secondary Objectives:

      • To characterize the pharmacokinetics (PK) and pharmacodynamics (PD) profiles of single
      ascending oral doses of ABP-671 in HVs.
    
  